1-20 of 93
Josep Maria Ribera, MD
Close
Sort by
Journal Articles

Final Results of the AML12 Trial of the Spanish Cetlam Group in Adults with Acute Myeloid Leukemia (AML) up to the Age of 70 Years: Risk Adapted Post-Remission Allocation Based on Genetic Data and Minimal Residual Disease

Jorge Sierra, MD, Ana Garrido, Marina Diaz Beya, MD, Montserrat Hoyos, Marisa Calabuig, MD, Susana Vives, MD, Montserrat Arnan Sangerman, MD PhD, Maria Paz Queipo De Llano, MD, Olga Salamero, MD, Ferran Vall-Llovera, MD, Alex Bataller, Francisca Guijarro, MD, Lourdes Escoda, MD, Antonio Garcia-Guiñon, MD, Brayan Merchan, MD MSc, Xavier Ortin, Isabel Sanchez Ortega, MD PhD, Marta Pratcorona, MD PhD, Joan Bargay, MD PhD, Antonia Sampol, Josep Nomdedeu, MD PhD, David Gallardo, Josep-Maria Ribera, MD PhD, Mar Tormo, Jordi Esteve, Salut Brunet, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 289.
https://doi.org/10.1182/blood-2019-128682
Published: 2019
Journal Articles

Ponatinib and Chemotherapy in Young Adults with De Novo Philadelphia Chromosome-Positive Acute Lymphoblstic Leukemia. Preliminary Results of Ponalfil Clinical Trial

Josep-Maria Ribera, MD PhD, Olga García, Pilar Martinez, MD, Pau Montesinos Fernandez, MD PhD, Blanca Boluda, Jordi Esteve, Daniel Esteban, María José Moreno, MD, Natalia Alonso, José González-Campos, MD, Arancha Bermúdez, Susana Vives, MD, Mar Tormo, MD PhD, Jesús María Hernández-Rivas, MD PhD, Joaquin Martinez-Lopez, MD PhD, Ramón García-Sanz, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3874.
https://doi.org/10.1182/blood-2019-125558
Published: 2019
Journal Articles

The Impact of Smoking on Survival in Patients (Pts) with Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Treated with the Combination of Intensive Therapy with Tyrosine Kinase Inhibitor (TKI)

Koji Sasaki, MD, Josep-Maria Ribera, MD PhD, Mary Figueroa, BS, Farhad Ravandi, MD, Nicholas J. Short, MD, Guillermo Garcia-Manero, MD, Naval G. Daver, MD, Tapan M. Kadia, MD, Marina Y Konopleva, MD PhD, Nitin Jain, MD, Ghayas C. Issa, MD, Zeev E. Estrov, MD, Rebecca Garris, MSc, Rita Khouri, Patrice Nasnas, MD, Courtney D. DiNardo, MDMSc, Kiran Naqvi, MDMPH, Steven M. Kornblau, MD, Guillermo Montalban-Bravo, MD, Naveen Pemmaraju, MD, Jorge E. Cortes, MD, Susan M. O'Brien, MD, Joya Chandra, PhD, Hagop M. Kantarjian, MD, Elias Jabbour, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3815.
https://doi.org/10.1182/blood-2019-129396
Published: 2019
Journal Articles

The Validation of the BCR/ABL1 -like Predictor across Laboratories Shows Reproducibility of Results

Sabina Chiaretti, MD PhD, Taherinasab Akram, Canichella Martina, Monica Messina, Alfonso Piciocchi, Cyril Šálek, MD PhD, Katerina Machova, Katerina Blagoevova, Jordi Ribera, PhD, Josep-Maria Ribera, MD PhD, Manja Meggendorfer, PhD, Claudia Haferlach, MD, Anna Guarini, PhD, Robin Foà, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5211.
https://doi.org/10.1182/blood-2019-122116
Published: 2019
Journal Articles

Subcutaneous Bortezomib, Thalidomide and Dexamethasone As Induction Therapy Prior to Autologous Peripheral Blood Stem Cell Transplantation in Young Patients Diagnosed of Multiple Myeloma. a Retrospective Analysis from Two Centers

David Jiménez Ruiz De La Torre, MD, Gladys Ibarra, MD, Maite Encuentra, Laura Abril, MD, Albert Oriol, MD, Josep-Maria Ribera, MD PhD, Anna Sureda, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5568.
https://doi.org/10.1182/blood-2019-130107
Published: 2019
Journal Articles

Rituximab and Specific Therapy for Patients with Burkitt's Leukemia and Lymphoma. Results of the BURKIMAB14 Trial from the Spanish Pethema and Geltamo Groups in 80 Patients

Josep-Maria Ribera, MD PhD, Olga García, Marta Cervera, MD, Carlos Rguez, Maialen Sirvent, Ferran Vall-Llovera, MD, Pau Abrisqueta, MD PhD, Josefina Serrano, Buenaventura Buendía, Pau Montesinos Fernandez, MD PhD, Susana Vives, MD, Juan Miguel Bergua Burgues, Mariana Beatriz Bastos-Oreiro, PhD MD, Evelyn Acuña, María José Moreno, MD, Irene García-Cadenas, Maria Jose Terol, Jesús María Hernández-Rivas, MD PhD, Antonio Garcia-Guiñon, MD, Pilar Herrera Puente, Santiago Mercadal, MD, Iulia Ivan, Antonia Cladera, Eva Gimeno Vázquez, Anna Torrent, Alfons Serrano-Maestro, MD, Cristina Barrenetxea, Daniel García, MD, Reyes Arranz, Ana Sebrango, Natalia Alonso, Daniel Martínez-Carballeira, MD, Juan-Manuel Sancho, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2584.
https://doi.org/10.1182/blood-2019-125683
Published: 2019
Journal Articles

Treatment of Adults with Minimal Residual Disease (MRD) Positive Acute Lymphoblastic Leukemia with Blinatumomab in a Real-World Setting: Results from the Neuf Study

Nicolas Boissel, MD PhD, Renato Bassan, MD, Josep-Maria Ribera, MD PhD, Sabina Chiaretti, MD PhD, Robin Foà, MD, Cristina Papayannidis, Naufil Alam, MSc, Alessandra Brescianini, PharmD, Isabella Pezzani, PharmD, Georg Kreuzbauer, MD, Alessandro Rambaldi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2624.
https://doi.org/10.1182/blood-2019-122931
Published: 2019
Journal Articles

Treatment of Adults with Relapsed/Refractory Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia with Blinatumomab in a Real-World Setting: Results from the Neuf Study

Nicolas Boissel, MD PhD, Josep-Maria Ribera, MD PhD, Sabina Chiaretti, MD PhD, Alessandro Rambaldi, MD, Renato Bassan, MD, Cristina Papayannidis, Naufil Alam, MSc, Alessandra Brescianini, PharmD, Isabella Pezzani, PharmD, Georg Kreuzbauer, MD, Robin Foà, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2627.
https://doi.org/10.1182/blood-2019-122917
Published: 2019
Journal Articles

Post-Remission Treatment with Chemotherapy or Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) in Adult Patients with High-Risk (HR) Philadelphia Chromosome-Negative (Ph-neg) Acute Lymphoblastic Leukemia (ALL) According to Their Minimal Residual Disease (MRD). Final Results of the Pethema ALL-HR-11 Trial

Josep-Maria Ribera, MD PhD, Mireia Morgades, M.Prob.S, Juana Ciudad, PhD, Pau Montesinos, MD PhD, Pere Barba, MD PhD, Irene García-Cadenas, María José Moreno, MD, Susana Vives, MD, Jordi Esteve, Cristina Gil, Silvia Monsalvo, MD, María Teresa Artola, MD, Jordi Ribera, PhD, Eulàlia Genescà, PhD, Mar Tormo, MD PhD, Marta Cervera, MD, Daniel Martínez-Carballeira, MD, Andrés Novo, MD, José González-Campos, MD, Beatriz Soria, MD, Arancha Bermúdez, MD, Aurelio López Martínez, MD, Santiago Mercadal, MD, Rosa Fernández-Martín, MD, Rosa Coll, MD, Josefina Serrano, Maria Luz Amigo, MD, Pilar Martínez-Sánchez, Juan-Miguel Bergua, MD, Alfons Serrano-Maestro, MD, Alberto Giménez Conca, MD, Susana Barrena, PhD, Isabel Granada, PhD, Evarist Feliu, MD PhD, Alberto Orfao, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 826.
https://doi.org/10.1182/blood-2019-123613
Published: 2019
Journal Articles

Characteristics and Outcome of Early T Cell Precursor ALL (ETP-ALL) Patients Treated with High-Risk Spanish Pethema Protocols

Eulalia Genesca, PhD, Mireia Morgades, M.Prob.S, Pau Montesinos, MD PhD, Pere Barba, MD, Cristina Gil, MD PhD, Ramon Guàrdia, MD, Maria Jose Moreno, MD, Daniel Martínez-Carballeira, MD, Irene García-Cadenas, Susana Vives, MD, Jordi Ribera, José González-Campos, MD, Marina Diaz-Beyá, MD, Santiago Mercadal, MD, Maria Teresa Artola, MD, Antonia Cladera, MD, Mar Tormo, MD PhD, Arancha Bermudez, MD, Ferran Vall-Llovera, MD, Pilar Martinez, MD, María-Luz Amigo, MD, Juan-Miguel Bergua, MD, María Calbacho, MD, Jesús-María Hernández-Rivas, MD PhD, Silvia Monsalvo, Andrés Novo, MD, Marta Cervera, MD, Antonio Garcia-Guiñon, MD, Jordi Junca, MD, Juana Ciudad, PhD, Alberto Orfao, MD PhD, Josep-Maria Ribera, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1553.
https://doi.org/10.1182/blood-2018-99-114559
Published: 2018
Journal Articles

Nilotinib (Tasigna ® ) and Low Intensity Chemotherapy for First-Line Treatment of Elderly Patients with BCR-ABL1- Positive Acute Lymphoblastic Leukemia: Final Results of a Prospective Multicenter Trial (EWALL-PH02)

Oliver G. Ottmann, MD, Heike Pfeifer, MD, Jean-Michel Cayuela, PhD, Karsten Spiekermann, MD, Wolfram Jung, MD, Joachim Beck, Emmanuel Raffoux, MD, Pascal Turlure, MD, Chantal Himberlin, Francoise Huguet, MD, Andreas Viardot, MD, Knut Wendelin, MD, Albrecht Reichle, MD, Sébastien Maury, MD PhD, Laurence Sanhes, MD, Francoise Isnard, PhD, Jean-Yves Cahn, MD, Stephane Lepretre, Patrice Chevallier, MD, Martine Escoffre-Barbe, MD, Josep-Maria Ribera, MD PhD, Dieter Hoelzer, MD PhD, Nicola Goekbuget, MD, Hervé Dombret, Philippe Rousselot, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 31.
https://doi.org/10.1182/blood-2018-99-114552
Published: 2018
Journal Articles

Targeted RNA-Seq Identify a Subset of Adolescent and Adult Patients with Acute Lymphoblastic Leukemia with BCR-ABL1-like Characteristics

Ricardo Sanchez, Mireia Morgades, M.Prob.S, Rosa Ayala, Esther Onecha, Yanira Ruiz-Heredia, Jose M. Sanchez, Susana Vives, MD, Santiago Mercadal, MD, Ramón Guardia, Marta Cervera, MD, Olga García, Jordi Ribera, Josep-Maria Ribera, MD, Joaquín Martínez
Journal: Blood
Blood (2017) 130 (Supplement 1): 2710.
https://doi.org/10.1182/blood.V130.Suppl_1.2710.2710
Published: 2017
Journal Articles

Baseline Biomarkers Influencing Clinical Outcomes in Adults with Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (R/R ALL) Treated with Blinatumomab Versus Standard-of-Care Chemotherapy (SOC) from a Randomized Phase 3 Study

Andrew Wei, MBBS, PhD FRACP, FRCPA, Josep-Maria Ribera, MD, Giovanni Martinelli, Richard A. Larson, MD, David Ritchie, MD PhD, Armin Ghobadi, MD, Yuqi Chen, Cedric E. Dos Santos, Zachary F. Zimmerman, MD PhD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2556.
https://doi.org/10.1182/blood.V130.Suppl_1.2556.2556
Published: 2017
Journal Articles

Bispecific Antibodies on Hematological Malignancies: A Novel Mechanism of Action That May Contribute to Therapeutic Efficacy

Daniel Primo, PhD, Pilar Hernandez, Javier de la Serna, MD, Josep-Maria Ribera, MD, Susana Vives, MD, Juan Bergua, MD, Jaime Perez de Oteyza, MD, Josefina Serrano, MD, Julian Gorrochategui, Vicente María Luisa, David Martínez-Cuadron, MD, Pau Montesinos, MD PhD, Joaquin Martinez Lopez, MD PhD, Joan Ballesteros, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2289.
https://doi.org/10.1182/blood.V130.Suppl_1.2289.2289
Published: 2017
Journal Articles

Ebv-Mir-BART11-3p, Ebv-Mir-BART9 and Ebv-Mir-BART10 Are Present in the Plasma of HIV-Infected Subjects with Lymphoma and Are Potential Lymphoma Biomarkers

Josep Muncunill, MSc, Maria Joao Baptista, PhD PharmD, Agueda Hernandez-Rodriguez, PhD, Judith Dalmau, PhD, Gustavo Tapia, MD PhD, Olga Garcia, Miriam Moreno, MD, Juan-Manuel Sancho, MD PhD, Javier Martinez-Picado, PhD, Josep-Maria Ribera, MD, Evarist Feliu, MD PhD, Jose-Luis Mate, MD PhD, Jose Tomas Navarro, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4004.
https://doi.org/10.1182/blood.V130.Suppl_1.4004.4004
Published: 2017
Journal Articles

Long-Term Follow-up of a Prospective Phase II Trial of Extended Treatment with Rituximab in Patients with B-Cell Post-Transplant Lymphoproliferative Disease and Comparison with a Cohort of Patients Treated in Real Life. Analysis on Behalf of the Spanish Lymphoma Group (GELTAMO)

Eva Gonzalez-Barca, MD PhD, Maria Queralt Salas Gay, MD, Francisco Javier Capote Huelva, Jose Gomez Codina, Carlos Panizo, MD PhD, Antonio Salar, MD PhD, Eva Domingo Domenech, MD, Alicia Bailen, Josep-Maria Ribera, MD, Andres Lopez, Javier Briones, MD, Andres Muñoz, Maite Encuentra, Alberto Fernandez de Sevilla, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1545.
https://doi.org/10.1182/blood.V130.Suppl_1.1545.1545
Published: 2017
Journal Articles

Therapy for Acute Myeloid Leukemia (AML) Adjusted to Genetic Data and Minimal Residual Disease: Results of the AML12 Trial of the Spanish Cetlam Group in Adults up to the Age of 70 Years

Jorge Sierra, Ana Garrido, MD, Susana Vives, MD, Maria Paz Queipo De Llano, Ramon Guàrdia, MD, Marina Diaz-Beyá, Marisa Calabuig, MD, Marta Pratcorona, Montserrat Arnan Sangerman, Olga Salamero, Marta Cervera, MD, Antonia Sampol, MD, Antoni Garcia-Guiñon, Carme Pedro, Josep M Marti, Joan Bargay, MD PhD, Llorenç Font, Josep F Nomdedeu, Montserrat Hoyos, Lourdes Escoda, Montserrat Batlle, Bryan Merchan, Isabel Sanchez-Ortega, Physician, Mar Tormo, MD PhD, David Gallardo, Josep-Maria Ribera, MD, Jordi Esteve, MD, Salut Brunet, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 567.
https://doi.org/10.1182/blood.V130.Suppl_1.567.567
Published: 2017
Journal Articles

Results of the Full Pediatric, Minimal Residual Disease (MRD)-Oriented Trial LAL-RI/2008 for Adolescents and Young Adults (AYA) with Standard Risk (SR), Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia (ALL)

Josep-Maria Ribera, MD, Mireia Morgades, M.Prob.S, Pau Montesinos, MD PhD, Daniel Martínez-Carballeira, MD, Cristina Gil, MD, Pere Barba, MD, Mar Tormo, MD PhD, Raimundo García-Boyero, MD, Ramon Guàrdia, MD, María Pedreño, MD, Santiago Mercadal, MD, Andrés Novo, MD, Jesús-María Hernández-Rivas, MD PhD, Juan Bergua, MD, José González-Campos, MD, María-Luz Amigo, MD, Marta Cervera, MD, Pilar Martínez-Sánchez, MD, Rodrigo Martino, MD PhD, María Calbacho, MD, Antoni Garcia-Guiñon, MD, Susana Vives, MD, Evarist Feliu, MD PhD, Alberto Orfao, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1273.
https://doi.org/10.1182/blood.V130.Suppl_1.1273.1273
Published: 2017
Journal Articles

Is the Outcome of Patients with High Risk T-Cell Acute Lymphoblastic Leukemia Improving in the Era of Pediatric—Inspired Protocols? a Comparison of 2 Consecutive Pethema Trials

Pere Barba, MD, Mireia Morgades, M.Prob.S, Pau Montesinos, MD PhD, Cristina Gil, MD, Maria Laura Fox, Juana Ciudad, maria Jose Moreno, José González-Campos, MD, Eulalia Genesca, Daniel Martínez-Carballeira, MD, Rodrigo Martino, MD PhD, Susana Vives, MD, Ramon Guàrdia, MD, Santiago Mercadal, MD, Maria Teresa Artola, Antonia Cladera, Mar Tormo, MD PhD, Jordi Esteve, MD, Juan Bergua, MD, Ferran Vall-Llovera, Jordi Ribera, Pilar Martínez-Sánchez, MD, María-Luz Amigo, MD, Arancha Bermudez, María Calbacho, MD, Jesús-María Hernández-Rivas, MD PhD, Evarist Feliu, MD PhD, Josep-Maria Ribera, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1323.
https://doi.org/10.1182/blood.V130.Suppl_1.1323.1323
Published: 2017
Journal Articles

Comparison of Efficacy and Safety of Two Types of E.coli Asparaginase (Native or Pegylated) for Treatment of Adult Patients with High-Risk (HR), Philadelphia (Ph) Chromosome-Negative ALL Included in the Prospective MRD-Oriented Protocol ALL-HR-11 from the Spanish Pethema Group

Josep-Maria Ribera, MD PhD, Mireia Morgades, MProbS, Pau Montesinos, MD PhD, Irene García-Cadenas, MD, Pere Barba, MD PhD, Beatriz Soria, MD, Arancha Bermúdez, MªJosé Moreno, MD, José González-Campos, MD, Susana Vives, MD, Cristina Gil, MD, Eugenia Abella, MD PhD, Ramon Guàrdia, MD PhD, Teresa Bernal, MD PhD, Pilar Martínez-Sánchez, MD, MªLuz Amigo, MD, Santiago Mercadal, MD, Alfons Serrano, MD, Aurelio López-Martínez, MD, Ferran Vall-llovera, MD, MªJosé Sánchez-Sánchez, MD, MªJesús Peñarrubia, MD PhD, María Calbacho, MD, Jose-Angel Méndez, MD, Juan Bergua, MD, Antònia Cladera, MD, Mar Tormo, MD, Daniel García-Belmonte, MD, Juana Ciudad, MD PhD, Evarist Feliu, MD PhD, Alberto Orfao, MD PhD
Journal: Blood
Blood (2016) 128 (22): 180.
https://doi.org/10.1182/blood.V128.22.180.180
Published: 2016